The phase three trials for ARCT-021, as the vaccine is called, will be conducted in three yet-to-be disclosed locations where the populations have yet to be vaccinated, Arcturus chief executive Joseph Payne told The Straits Times.
Will they disclose which locations.?? I rather not be a guinea...